Genetic variants in FCGR2A and FCGR3A and disease-free survival in patients with HER2 positive breast cancer treated with trastuzumab in the SUCCESS A trial

M Wunderle, A Hein, B Rack, L Häberle, L Li, AB Ekici, A Reis, MP Lux, JM Cunningham, M Rübner, A Schneeweiss, H Tesch, JU Blohmer, T Fehm, G Heinrich, M Rezai, MW Beckmann, W Janni, RM Weinshilboum, L Wang, PA Fasching · Senologie - Zeitschrift für Mammadiagnostik und -therapie · 2018 · Heft 02